97 related articles for article (PubMed ID: 21888299)
1. Compromising the medical literature: the hidden influence of industry-biased articles.
Fugh-Berman A; Siwek J
Am Fam Physician; 2011 Sep; 84(5):489-90. PubMed ID: 21888299
[No Abstract] [Full Text] [Related]
2. Diabetic peripheral neuropathic pain: is gabapentin effective?
Hyatt JD; Daniel D; Tran QV; Millares M; Kubota DR
Am Fam Physician; 2011 Sep; 84(5):480, 482; author reply 482. PubMed ID: 21888297
[No Abstract] [Full Text] [Related]
3. Confounding factors in off-label drug use.
Greenberg PE; Pike C; Sisitsky T
Health Aff (Millwood); 2012 Feb; 31(2):460; author reply 460. PubMed ID: 22323178
[No Abstract] [Full Text] [Related]
4. Dr. Vieta replies.
Vieta E
J Clin Psychiatry; 2013 Aug; 74(8):854. PubMed ID: 24021510
[No Abstract] [Full Text] [Related]
5. Apparent discrepancy between published study of gabapentin treatment and internal company report.
Mayo-Wilson E
J Clin Psychiatry; 2013 Aug; 74(8):853-4. PubMed ID: 24021509
[No Abstract] [Full Text] [Related]
6. Outcome reporting in industry-sponsored trials of gabapentin for off-label use.
Vedula SS; Bero L; Scherer RW; Dickersin K
N Engl J Med; 2009 Nov; 361(20):1963-71. PubMed ID: 19907043
[TBL] [Abstract][Full Text] [Related]
7. Reporting of trials of gabapentin.
Gordh TE; Jensen TS; Kalso E
N Engl J Med; 2010 Apr; 362(17):1641; author reply 1641-2. PubMed ID: 20427815
[No Abstract] [Full Text] [Related]
8. Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern?
Goodman CW; Brett AS
N Engl J Med; 2017 Aug; 377(5):411-414. PubMed ID: 28767350
[No Abstract] [Full Text] [Related]
9. Gabapentin for Chronic Neuropathic Pain.
Moore A; Derry S; Wiffen P
JAMA; 2018 Feb; 319(8):818-819. PubMed ID: 29486015
[TBL] [Abstract][Full Text] [Related]
10. Off-label marketing stirs a legal hornet's nest.
Guglielmo WJ
Med Econ; 2006 Oct; 83(19):47-9. PubMed ID: 17066854
[No Abstract] [Full Text] [Related]
11. Gabapentin and tinnitus relief.
Shulman A
Int Tinnitus J; 2008; 14(1):1-5. PubMed ID: 18616079
[No Abstract] [Full Text] [Related]
12. False Claims Act prosecution did not deter off-label drug use in the case of neurontin.
Kesselheim AS; Darby D; Studdert DM; Glynn R; Levin R; Avorn J
Health Aff (Millwood); 2011 Dec; 30(12):2318-27. PubMed ID: 22147859
[TBL] [Abstract][Full Text] [Related]
13. Gabapentin in dermatology.
Misery L
Dermatology; 2005; 211(2):79-80. PubMed ID: 16088149
[No Abstract] [Full Text] [Related]
14. [Idiopathic senile pruritus: therapeutic response to gabapentin].
Ruiz-Villaverde R; Sánchez-Cano D
Rev Esp Geriatr Gerontol; 2009; 44(6):355-6. PubMed ID: 19720432
[No Abstract] [Full Text] [Related]
15. Gabapentin in carpal tunnel patients: A consideration.
Wiwanitkit V
Neurol India; 2009; 57(5):690. PubMed ID: 19934586
[No Abstract] [Full Text] [Related]
16. Gabapentin for uraemic pruritus.
Manenti L; Vaglio A
Nephrol Dial Transplant; 2005 Jun; 20(6):1278-9. PubMed ID: 15840668
[No Abstract] [Full Text] [Related]
17. Gabapentin for the prophylaxis of episodic migraine in adults.
Fogleman CD
Am Fam Physician; 2014 May; 89(9):714-5. PubMed ID: 24784332
[No Abstract] [Full Text] [Related]
18. Efficacy of gabapentin in the management of pruritus of unknown origin.
Yesudian PD; Wilson NJ
Arch Dermatol; 2005 Dec; 141(12):1507-9. PubMed ID: 16365250
[No Abstract] [Full Text] [Related]
19. Off-label prescribing explained. Why your doctor may recommend meds that aren't FDA-approved for your condition.
Johns Hopkins Med Lett Health After 50; 2011 Jun; 23(4):7. PubMed ID: 21702115
[No Abstract] [Full Text] [Related]
20. Seeding trials and the subordination of science.
Alexander GC
Arch Intern Med; 2011 Jun; 171(12):1107-8. PubMed ID: 21709112
[No Abstract] [Full Text] [Related]
[Next] [New Search]
